Default: Journal of Comparative Effectiveness Research

ISSN: 2042-6305

Journal Home

Journal Guideline

Journal of Comparative Effectiveness Research Q2 Unclaimed

United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Comparative Effectiveness Research is a journal indexed in SJR in Health Policy with an H index of 39. It has a price of 2100 €. It has an SJR impact factor of 0,708 and it has a best quartile of Q2. It has an SJR impact factor of 0,708.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Health Policy (Q2)
Price

2100 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Journal of Comparative Effectiveness Research

0,708

SJR Impact factor

39

H Index

95

Total Docs (Last Year)

359

Total Docs (3 years)

2502

Total Refs

731

Total Cites (3 years)

331

Citable Docs (3 years)

2.17

Cites/Doc (2 years)

26.34

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Cost-effectiveness thresholds in the USA: are they coming? Are they already here?

View more

A comparison of outcomes for early oropharyngeal cancers treated with single-modality surgery versus radiotherapy

View more

Introducing Volume 8 of the Journal of Comparative Effectiveness Research

View more

Comparison of conservative treatment with appendectomy for acute uncomplicated pediatric appendicitis: a meta-analysis

View more

Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians

View more

Comparative outcome of induced labor by intracervical Foley catheter with misoprostol versus misoprostol alone

View more

Comparing twice- versus four-times daily insulin in mothers with gestational diabetes in Pakistan and its implications

View more

Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction

View more

Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs

View more

Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers

View more

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

View more

Using comparative effectiveness research to remedy health disparities

View more
SHOW MORE ARTICLES

RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma

View more

Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure

View more

Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe

View more

Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settings

View more

Why are patients uncertain about the human papillomavirus vaccine's effectiveness?

View more

Comparative effectiveness of renin-angiotensin system inhibitors in hypertension

View more

Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease

View more

Patient and clinician views on comparative effectiveness research and engagement in research

View more

Comparative effectiveness of surgery versus antibiotics in acute appendicitis: a systematic review

View more

Reporting and analyses of sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals

View more

Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future

View more

Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors

View more

FAQS